You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 34 No. 5, May 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Increased Norepinephrine Levels and Decreased Dopamine-β-Hydroxylase Activity in Primary Autism

C. Raymond Lake, MD, PhD; Michael G. Ziegler, MD; Dennis L. Murphy, MD

Arch Gen Psychiatry. 1977;34(5):553-556.


Abstract

• The sympathetic nervous system was evaluated in 11 primary autistic patients and their families. The plasma levels of norepinephrine (NE), the neurotransmitter of the sympathetic nervous system, was higher in the patients than in age-controlled normal volunteers both while supine and after standing. The plasma activity of dopamine-β-hydroxylase, the enzyme that converts dopamine to NE, was significantly lower in the autistic patients and their healthy relatives than in control groups. Dopamine-β-hydroxylase does not appear to provide an index of sympathetic activity in this group of patients who, on the basis of the elevated plasma levels of NE, may demonstrate a chronic state of hyperactivity of the sympathetic nervous system. Low enzyme activity found in both the autistic patients and their immediate families may be associated with this disorder.



Author Affiliations

From the Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Md. Dr Ziegler is now with the Department of Pharmacology, University of Texas Medical Branch, Galveston.


Footnotes

Accepted for publication Jan 26, 1977.

Reprint requests to Laboratory of Clinical Science, National Institute of Mental Health, Bldg 10, Room 2D-46, Bethesda, MD 20014 (Dr Lake).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Pediatric Neurotransmitter Disorders
Pearl et al.
J Child Neurol 2007;22:606-616.
ABSTRACT  

Cardiovascular Arousal in Individuals With Autism
Goodwin et al.
Focus Autism Other Dev Disabl 2006;21:100-123.
ABSTRACT  

The psychopharmacology of autism and related disorders
Gillberg
J Psychopharmacol 1996;10:54-63.
 

The Neurobiology of Infantile Autism
Ciaranello and Ciaranello
Neuroscientist 1995;1:361-367.
ABSTRACT  

Autism and Genetics: A Decade of Research
Smalley et al.
Arch Gen Psychiatry 1988;45:953-961.
ABSTRACT  

Dopamine {beta}Hydroxylase in CSF: Relationship to Personality Measures
Major et al.
Arch Gen Psychiatry 1980;37:308-310.
ABSTRACT  

Platelet Monoamine Oxidase and Serum Dopamine-{beta}-Hydroxylase Activity in Chronic Alcoholics
Sullivan et al.
Arch Gen Psychiatry 1978;35:1209-1212.
ABSTRACT  

Plasma Levels of Norepinephrine
KOPIN et al.
ANN INTERN MED 1978;88:671-680.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.